BrainsWay Ltd. (NASDAQ:BWAY) Q3 2022 Results Earnings Conference Call November 16, 2022 8:30 AM ET
Company Participants
Bob Yedid - Investor Relations, LifeSci Advisors
Christopher von Jako - President and Chief Executive Officer
Scott Areglado - Chief Financial Officer
Conference Call Participants
Steven Lichtman - Oppenheimer & Co. Inc.
Jeffery Cohen - Ladenburg Thalmann
Jayson Bedford - Raymond James & Associates, Inc.
Boobalan Pachaiyappan - H.C. Wainwright & Co.
Jason Wittes - Loop Capital
Operator
Ladies and gentlemen, greetings and welcome to the BrainsWay third quarter 2022 earnings conference call. At this time, all participants are in a-listen only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Bob Yedid of LifeSci Advisors. Please go ahead.
Bob Yedid
Thank you. And welcome to BrainsWay's third quarter 2022 earnings conference call. With us today are BrainsWay's President and Chief Executive Officer, Chris von Jako, and Chief Financial Officer, Scott Areglado.
The format for today's call will be a discussion of recent trends and business updates from Chris, followed by a detailed discussion of the financials from Scott. Then we will open up the call for your questions.
Earlier today, BrainsWay released financial results for the three and nine months ended September 30, 2022. Copy of the press release is available on the company's Investor Relations website.
Before I turn the call over to Chris and Scott, I would like to remind you that this conference call, including both management's prepared remarks and the question-and-answer session, may contain projections or other forward-looking statements regarding, among other topics, BrainsWay's anticipated future operating and financial results, business plans and prospects, and expectations for its products and pipeline, which are all subject to risk and uncertainties, including shifting market conditions resulting from the COVID-19 pandemic, the global supply chain constraints, as well as the use of non-GAAP financial information.
Additional information regarding these and other risks are available in the company's earnings release and its other filings with the Securities and Exchange Commission, including the Risk Factors section contained in BrainsWay's Form 20-F.
With those prepared remarks, it's my pleasure to turn the call over to Chris von Jako. Chris?
Christopher von Jako
Thank you, Bob. Welcome, everyone. And thank you for joining us today. To begin, as I stated on our last call, the current macroeconomic environment, including staffing shortages, higher interest rates, inflation, and recessionary fears continued to impact our customers and patients and in turn our third quarter results.